RecruitingPhase 1NCT06361485

Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Lumbar Pain


Sponsor

R3 Stem Cell

Enrollment

100 participants

Start Date

Mar 25, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This is a Pilot Study that is an open label, prospective, non-controlled study in which the safety and feasibility of Wharton's Jelly (WJ) allograft will be evaluated in 100 participants suffering with low back pain.


Eligibility

Min Age: 20 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a biological treatment called Lumbar Injections with 10cc's of Wharton's Jelly Allograft for people with low back pain. The study is currently recruiting participants at 4 locations. People eligible for this study include aged 20 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALLumbar Injections with 10cc's of Wharton's Jelly Allograft

Low Back Injections with Minimal Manipulation Umbilical Cord Tissue


Locations(4)

R3 Anti Aging Scottsdale

Scottsdale, Arizona, United States

R3 Anti Aging Beverly Hills

Beverly Hills, California, United States

Scheer Medical Wellness

New York, New York, United States

Dr. Duc (Steve) Le, MD

Cleveland, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06361485


Related Trials